Neurology Service, Erzincan Military Hospital, Erzincan, Turkey.
J Neurol Sci. 2012 May 15;316(1-2):76-8. doi: 10.1016/j.jns.2012.01.023. Epub 2012 Feb 13.
With the use of musculoskeletal ultrasonography (MSUS), morphological changes in the median nerve have been recently reported in patients with carpal tunnel syndrome (CTS). On the other hand, the literature still lacks the information whether those changes are further altered with steroid and local anesthetic injection which is a widely used treatment in this group of patients. Therefore, the aim of our study was to explore in-vivo the effects of steroid with repetitive procaine HCl injection on the median nerve of patients with CTS.
This prospective clinical trial followed-up patients for 2 months. 22 patients (37 median nerves) with clinical and electrophysiological evidence of CTS were included in the study. All patients received both 40 mg of triamcinolone acetonide once and 4 ml of 1% procaine HCl twice a week for 2 weeks with the same technique. Clinical, functional, electrophysiological and ultrasonographic evaluations were performed at the study onset, and 2 months after the last injection.
Electrophysiological, ultrasonographic findings (median nerve anterior-posterior diameter, transverse diameter and cross sectional area in the proximal carpal tunnel and volar bulging,) VAS scores, Boston carpal tunnel symptom and function assessment scale improved significantly (P<0.05).
Steroid injection with repetitive procaine HCl injection effectively reduced the symptoms of CTS, improved the Boston carpal tunnel symptom and function assessment scale and also electrophysiological and ultrasonographic findings. Long term effects remain to be studied. Indisputably, the use of MSUS seems to be promising in this regard.
肌骨超声(MSUS)的应用使人们最近发现腕管综合征(CTS)患者正中神经的形态学变化。另一方面,文献中仍然缺乏关于这些变化是否会因类固醇和局部麻醉剂注射而进一步改变的信息,而类固醇和局部麻醉剂注射是该组患者的常用治疗方法。因此,我们的研究目的是探讨类固醇联合反复盐酸普鲁卡因注射对 CTS 患者正中神经的体内影响。
这项前瞻性临床试验对患者进行了 2 个月的随访。纳入了 22 名(37 条正中神经)有临床和电生理证据的 CTS 患者。所有患者均接受每周 40mg 曲安奈德一次和 1%盐酸普鲁卡因 4ml 两次治疗,共 2 周,采用相同技术。在研究开始时和最后一次注射后 2 个月进行临床、功能、电生理和超声评估。
电生理、超声检查结果(正中神经前后径、腕管近端横径和横截面积及掌侧隆起)、视觉模拟评分(VAS)、波士顿腕管症状和功能评估量表均显著改善(P<0.05)。
类固醇联合反复盐酸普鲁卡因注射可有效减轻 CTS 症状,改善波士顿腕管症状和功能评估量表,以及电生理和超声检查结果。长期效果仍需研究。不可否认的是,MSUS 的应用在这方面似乎很有前景。